- Home
- ZEPP vs SER Comparison
ZEPP vs SER Comparison
Compare ZEPP & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZEPP
- SER
- Stock Information
- Founded
- ZEPP 2013
- SER 2017
- Country
- ZEPP China
- SER United States
- Employees
- ZEPP N/A
- SER N/A
- Industry
- ZEPP Computer Manufacturing
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- ZEPP Technology
- SER Health Care
- Exchange
- ZEPP Nasdaq
- SER Nasdaq
- Market Cap
- ZEPP 44.0M
- SER 44.8M
- IPO Year
- ZEPP N/A
- SER 2018
- Fundamental
- Price
- ZEPP $2.85
- SER $4.60
- Analyst Decision
- ZEPP
- SER
- Analyst Count
- ZEPP 0
- SER 0
- Target Price
- ZEPP N/A
- SER N/A
- AVG Volume (30 Days)
- ZEPP 17.0K
- SER 18.4K
- Earning Date
- ZEPP 03-17-2025
- SER 11-12-2024
- Dividend Yield
- ZEPP N/A
- SER N/A
- EPS Growth
- ZEPP N/A
- SER N/A
- EPS
- ZEPP N/A
- SER N/A
- Revenue
- ZEPP $208,946,095.00
- SER $3,157,500.00
- Revenue This Year
- ZEPP N/A
- SER N/A
- Revenue Next Year
- ZEPP $18.94
- SER N/A
- P/E Ratio
- ZEPP N/A
- SER N/A
- Revenue Growth
- ZEPP N/A
- SER 2454.55
- 52 Week Low
- ZEPP $2.06
- SER $3.81
- 52 Week High
- ZEPP $5.72
- SER $23.18
- Technical
- Relative Strength Index (RSI)
- ZEPP 52.15
- SER 50.80
- Support Level
- ZEPP $2.61
- SER $4.60
- Resistance Level
- ZEPP $2.84
- SER $4.92
- Average True Range (ATR)
- ZEPP 0.18
- SER 0.34
- MACD
- ZEPP -0.01
- SER 0.02
- Stochastic Oscillator
- ZEPP 65.01
- SER 38.75
About ZEPP Zepp Health Corporation
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in two segments: Xiaomi Wearable Products and Self-branded products & others. The product portfolio includes smartwatches and fitness bands. The majority is from Self-branded products & other segments. It generates majority of the revenue from Xiaomi Wearable Products segment.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.